@article{ed3e0c4900ce43989aadfd1b0954dbc6,
title = "Can Osteoblastoma Evolve to Malignancy? A Challenge in the Decision-Making Process of a Benign Spine Tumor",
keywords = "En bloc resection, Enneking appropriate resection, Malignancy, Osteoblastoma, Osteosarcoma, Primary spine tumor, antineoplastic agent, adult, Article, backache, bone biopsy, cancer chemotherapy, cancer growth, cancer radiotherapy, cancer recurrence, cardiotoxicity, clinical article, clinical decision making, clinical outcome, drug withdrawal, histopathology, human, human tissue, ionizing radiation, limb weakness, lung metastasis, male, malignant transformation, multimodality cancer therapy, nuclear magnetic resonance imaging, osteoblastoma, osteoid osteoma, osteosarcoma, paraplegia, positron emission tomography, proton therapy, radiation dose distribution, radiofrequency ablation, re-irradiation, systemic disease, x-ray computed tomography",
author = "A. Mesfin and S. Boriani and M. Gambarotti and S. Bandiera and A. Gasbarrini",
note = "Export Date: 26 February 2020",
year = "2020",
doi = "10.1016/j.wneu.2019.11.148",
language = "Italian",
volume = "136",
pages = "150--156",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
}